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Abstract
Background: Ethnic, intersubject, interoperator and intermachine differences in measured macular thickness seem to 
exist. Our purpose was to collect normative macular thickness data in Norwegians and to evaluate the association 
between macular thickness and age, gender, parity, and contraception status.
Methods: Retinal thickness was measured by Stratus Optical Coherence Tomography in healthy subjects. Mean 
macular thickness (MMT) was analyzed by repeated measures ANOVA with three dependent regional MMT-variables 
for interaction with age, gender, parity and oral contraception use. Exploratory correlation with age by the Pearson 
correlation test, both before and after stratification by gender was performed. Differences in MMT between older and 
younger subjects, between oral contraception users and non-users, as well as parous and nulliparous women were 
studied by post-hoc Student's t-tests.
Results: Central MMT in Norwegians was similar to values earlier reported in whites. MMT in central areas of 1 and 2.25 
mm in diameter were higher in males than in females. In younger subjects (≤43 years) differences in MMT between 
genders were larger than in the mixed age group, whereas in older subjects (>43 years) the small differences did not 
reach the set significance level. No differences were found in minimal foveolar thickness (MMFT) between the genders 
in any age group.
Mean foveal thickness (1 mm in diameter) was positively associated with age in females (r = 0.28, p = 0.03). MMFT was
positively associated with age in all groups and reached significance both in females and in mixed gender group (r =
0.20, p = 0.041 and r = 0.26, p = 0.044 respectively).
Mean foveal thickness and MMFT were significantly higher in parous than in nulliparous women, and age-adjusted
ANOVA for MMFT revealed a borderline effect of parity.
Conclusions: Age and gender should be taken into consideration when establishing normal ranges for MMT in 
younger subjects. The gender difference in retinal thickness in young, but not older adults suggests a gonadal 
hormonal influence. The possible association between parity and retinal structure and its clinical relevance, should be 
studied further.
Background
In vivo qualitative and quantitative imaging of the retina
by the optical coherence tomography (OCT) [1] is non-
invasive, obtainable and reproducible even on non-
dilated eyes [2-4] in both healthy subjects and in patients
with macular pathology [5,6].
Macular aging involves alterations in its function,
structure [7] and blood supply [8], which are partly
induced by chronic low-grade inflammation [9]. Complex
multifactorial genetic and environmental factors may
accelerate the aging process or trigger a progressive and
irreversible loss of central vision [10], as in age-related
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macular degeneration [11,12]. Some of these factors seem
to be modulated by gonadal sex hormones [13-15].
Sex-related differences exist in both healthy and dis-
eased eyes [16,17], and several sight threatening retinal
conditions like age-related macular degeneration and
idiopathic macular holes have been associated with the
female gender and reproductive history [18-20]. It has
been suggested that the macula in females, being thinner,
is more vulnerable than in males.
However, there is inconsistency as to whether mean
macular thickness (MMT) varies with age and gender in
published papers. Both gender specific sex hormones and
age related hormonal changes in women are known to
influence macular function [21,22]. Although there is a
growing body of evidence that estrogens influence main-
tenance of retinal function and integrity [23,24], little is
known about their effects on MMT measured by the
OCT.
Ethnic differences exist in the prevalence of age-related
macular degeneration [25], gonadal hormone levels in
women [26] and in MMT [27-30], and may explain some
of the variations in the published literature. Since the
prevalence of early age-related maculopathy appears to
be higher in the urban Norwegian population than in
other populations [31] and that menopause possibly
occur earlier in Norwegians (about 50 years) than in
Europe (about 54 years) [32-35], we hypothesized that
MMT measurements in Norwegians could differ from
measurements in other populations. There are also inter-
subject, interoperator and intermachine variability in
measured MMT, even when identical OCT versions are
being used [36].
The purpose of the present study was to collect norma-
tive data on the Stratus OCT in Norwegians. We also
assessed the effect of age, gender, parity and the use of
oral contraception on macular thickness in our study
sample.
Methods
Subjects were prospectively recruited from students and
staff at St. Olavs University Hospital. Inclusion criteria
were best corrected visual acuity (Humphery automatic
refractor HARK 597, Dublin, CA) better than 0.8 with
spheric equivalent of ±6, no current medical eye history
(uncomplicated refractive surgery >2 years prior to
enrollment was accepted), no evidence of pathology on
slit lamp microscopy with 90-diopter lens, no significant
lens opacities and normal intraocular pressure. Subjects
with diabetes or systemic inflammatory conditions were
not included.
Initially 258 phakic, healthy-appearing eyes of 129 sub-
jects were included. Fifteen single eyes of 15 subjects
were excluded because they applied diclofenac or dexam-
ethasone topically for three days in one eye (parallel
study). Eighteen subjects (bilateral scans) and 18 single
eyes (of 16 subjects) were excluded due to low OCT sig-
nal, badly defined interfaces, alignment problems and/or
missing data on the scan. Two subjects were excluded in
spite of good OCT quality; one subject had eye symptoms
with "foggy sight" despite normal eye examination,
another had had heavy head trauma several years prior to
examination.
Overall 185 OCT scans of 107 subjects, 78 bilateral and
29 unilateral were eligible for inclusion. Only one eye of
each subject was included, laterality was randomly cho-
sen (where bilateral scans were available).
All subjects gave their informed consent. The study was
approved by the Regional Ethics Committee in May 2005.
It was conducted in accordance with the Declaration of
Helsinki recommendations. Subjects were included
between September 2007 and September 2008.
Both eyes were examined and bilateral OCT (Optic
Coherence Tomography STRATUS, Carl Zeiss Meditec,
Inc., Dublin, CA) scans were obtained by a single opera-
tor on all eyes. Medical history was taken during the ses-
sion, which included an optional interview about the use
of hormonal contraception (44 of 62 women participated)
and childbirth (57 of 62 women participated). If subjects
consented to an extended examination, a multifocal elec-
troretinography was also performed for future publica-
tions.
OCT was recorded in Macular Thickness Protocol
(software v.5.0.1). Spherical values closest to subject's
refraction were adjusted in the OCT, even though studies
had shown that this did not affect macular thickness mea-
surements significantly [2,37]. A few myopic soft contact
lens users were allowed to keep the correction on. The
room was darkened to gain maximal undilated pupil size
and volunteers were asked to gaze at the internal fixation
mark within the OCT, while six radial retinal scans were
taken.
The scans were obtained at equally spaced angular ori-
entation centered on the foveola. MMT is generated by
the OCT software algorithms by calculating the distance
between the vitreoretinal interface and the boundary
between the inner and outer photoreceptor segment in
microns. Each 6 millimeter long scan takes measure-
ments at 512 points, with higher density near the foveola.
Mean macular thickness (MMT) is then calculated auto-
matically and reported.
Pharmacological dilatation was not routinely applied,
as it is not a necessary procedure for Stratus OCT [3,4].
However, noisy scans were retaken after dilatation with
tropicamide 0.5% one drop in each eye if subjects con-
sented (after removing contact lenses). Eye movements,
fixation losses and blinks prolonged the procedure, while
undilated pupils [38] and soft contact lenses [39] deterio-
rated the signal strength. Barkana et al. [40] found thatWexler et al. BMC Ophthalmology 2010, 10:13
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signal strength did not affect any measured MMT param-
eters when scans with signal strength ≥4 (out of maxi-
mum ten) were included (using the fast macular protocol)
[40]. Moreover, Muscat et al. [41] showed that even con-
siderably degraded signal strength produced accurate,
precise and reproducible MMT measurements.
Scans with well defined interfaces and signal strength
better than three were included. Measured MMT could
vary with axial length and refraction by altering the area
measured in a scan, because the default axial length in the
STRATUS OCT is set to 24.45 mm. A longer axial length
and myopia results in axial magnification and a larger cir-
cle area would be measured [37]. However, since periph-
eral MMT measurements are more susceptible to axial
magnification than central [37], and there is high concor-
d a n c e  i n  m e a s u r e d  M M T  i n  t h e  c e n t r a l  a r e a s  b y  t h e
shorter (3.45 mm) and the longer (6 mm) scan length
mapping protocols [42], the shorter (3.45 mm) scan
length was chosen (even though no high myopes were
included).
In this protocol the macula is divided into 9 areas:
Mean foveal thickness (MFT = F1) from a central macu-
lar area of one millimeter in diameter, the inner ring (F2-
F5) and the outer ring (F6-F9), each divided into four
quadrants. The outer ring diameters measured 2.22 and
3.45 millimeters respectively. Regional variables MCT
(mean central thickness) and MPT (mean peripheral
thickness) were defined by averaging middle (MCT = (F2
+ F3 + F4 + F5)/4) and outer (MPT = (F6 + F7 + F8 + F9)/
4) ring data (Fig. 1). Mean total averaged macular thick-
ness (MTT) was calculated by averaging the nine macular
areas (F1 + F2 + F3 + F4 + F5 + F6 + F7 + F8 + F9)/9. The
inner region (MFT = F1) and mean minimal foveolar
thickness (MMFT = F0) were also analyzed.
Participants were categorized in 11 partly overlapping
subgroups according to age, parity, gender and oral con-
traception use. Parity was defined by delivering a live-
borne child, contraception users were defined by use of
oral contraception for at least three month prior to inclu-
sion. No pregnant women were included. These sub-
groups are described, together with their mean OCT
signal strength in Table 1.
One OCT scan of each subject was included, laterality
was randomly chosen if bilateral scans were available, so
that equal amount of right (n = 54) and left (n = 53) eyes
were included. Signal strength was 4 or 5 in 38 scans, 6 or
7 in 43 scans and 8 to 10 in 26 included scans. MMT in
the above described macular areas were analyzed and
compared between the groups.
Regional variables MFT, MCT and MPT were analyzed
with repeated measures ANOVA with age as covariate
and gender as the grouping factor. Within-subject factors
were assessed with multivariate repeated measures analy-
sis. In women we performed two additional ANOVAs,
one with parity and another with contraception use as
grouping factors.
The associations between MMFT (foveola), age and
either gender, parity, or contraceptives were studied by
three separate ANOVAs with MMFT as the dependent
variable.
MMT was also explored for statistical association with
age in three separate groups (all 107 subjects, male sub-
group and female subgroup) with the Pearson correlation
test for the five macular variables (MMFT, MFT, MCT,
MPT and MTT).
MMT in these five macular regions was analyzed with
independent sample Student's t-tests for differences
between the genders in three different groups: comparing
males with females, younger males with younger females
and older males with older females. MMT in parous
women was compared with nulliparous women, and oral
contraception users were compared with non-users by
the same tests.
Data were analyzed in SPSS 16. All tests were two-sided
and a p-value < 0.05 was considered statistically signifi-
cant.
Results
Normal mean regional MMT-values are reported in
Table 2. Males had higher MMT values than females in
central macular regions except MMFT (Table 2). In
repeated measures ANOVA gender did affect MMT sig-
nificantly (p = 0.001; Table 3). Significant interaction
between region and gender was found (p = 0.009; Table
3).
In repeated measures ANOVA age was not significantly
associated with MMT, although we observed a trend
when females were analyzed separately (p = 0.1); Table 3).
Figure 1 Macular areas on the Stratus OCT scan. Outer diameter of 
the outer, middle and inner rings are 3.45, 2.22 and 1 millimeters re-
spectively. The foveal point in the center of F1 represents the mean 
minimal foveolar thickness (MMFT = F0). Mean foveal thickness (MFT) 
is measured in area F1. Regional thickness variables for regions MCT 
(mean central thickness) = (F2 + F3 + F4 + F5)/4, MPT (mean peripheral 
thickness) = (F6 + F7 + F8 + F9)/4 and MTT (mean total thickness) = (F1 
+ F2 + F3 + F4 + F5 + F6 + F7 + F8 + F9)/9 were calculated.
Nasal
 MCT
MPT  F7
F3
F4 F2
F5
F9
F8 F6 F1
MFTWexler et al. BMC Ophthalmology 2010, 10:13
http://www.biomedcentral.com/1471-2415/10/13
Page 4 of 9
In the exploratory correlation analysis of MMT, we found
a small but significant positive correlation between MFT
and age in females (r = 0.28 p = 0.03) (Table 4; Fig. 2), and
between MMFT and age in both females (r = 0.26 p =
0.044) and mixed-gender group (r = 0.20 p = 0.041) (Table
4). However, r-values were generally small, explaining less
than 8% of the variance.
Differences between the genders in all central MMT
regions (except MMFT) were significant in younger sub-
jects (Table 5; Fig. 3) and in mixed-age group (Table 2),
measuring higher values in males. Differences in MMT
were non-significant in older subjects (Table 5).
Age-adjusted ANOVA for MMFT revealed a borderline
effect for parity (F = 3.5, p = 0.066). No significant inter-
action between region and parity was observed (Table 3).
However, with post-hoc Studen's t-tests MMFT, and
MFT were observed to be significantly higher in parous
compared to nulliparous women (Table 6; Fig. 4). Differ-
ences in MMT between women with and without oral
contraception were not found.
Discussion
Our measurements of MMT in central macular areas are
in good agreement with other studies conducted on the
Stratus OCT in whites. MMFT (foveola) was 177(SD 20)
and MFT (fovea) 209 (15) in the female group while Liew
et al. [43] found thicknesses of 178(23) and 212(19) in
same areas in females aged 17 - 50 years. Chamberlain et
al. [44] reported MFT of 210.3 (21) in Australian whites
aged 50-80 years and Chan et al. [45] reported foveal
MMT of 212(20) in mixed gender group, which is similar
to our measured MFT of 213(16) in the mixed gender
group. Evaluation of exact MMT in the more peripheral
areas is difficult unless the same scan length is being
used. MMT measurements in Norwegians do not seem to
Table 1: Subjects in partly overlapping subgroups according to age, parity, gender and contraception status.
Group Number of
subjects
Mean age (SD)
in years
Age range Mean OCT
signal strength(SD)
All participants 107 42.4(11.8) 21-63 6.3(1.7)
Males 45 39.2(12.0) 22-63 6.0(1.9)
Females 62 44.7(11.2) 21-61 6.5(1.6)
Younger* males 29 31.6(6.3) 22-42 6.3(2.0)
Younger females 27 33.8(7.0) 21-43 6.1(1.5)
Older** males 16 52.9(5.9) 44-63 5.4(1.5)
Older females 35 53.0(4.7) 44-61 6.7(1.6)
Parous women 34 46.7(8.4) 28-60 6.7(1.4)
Nulliparous womean 23 40.0(14.3) 21-61 6.2(1.7)
Women using oral 
contraception
10 33.5(9.5) 21-53 6.0(1.8)
Women not using oral 
contraception
33 48.0(10.3) 24-60 6.7(1.4)
OCT: optical coherence tomography. *age ≤43 (mean age for all participants), **age >43
Table 2: MMT (SD) (in micron) in five regions related to gender in 107 healthy subjects.
Macular regions Both genders (n = 
107)
Males (n = 45) Females (n = 62) p-value1
F0 (MMFT) 178(22) 179(21) 177(20) 0.47
Inner ring F1(MFT) 213(16) 218(16) 209(15) 0.002
Middle ring (MCT) 272(15) 279(15) 268(13) <0.0005
Outer ring (MPT) 274(14) 277(16) 272(13) 0.14
Total region (MTT) 267(13) 271(14) 263(12) 0.003
MMT: mean macular thickness MMFT: mean minimal foveolar thickness, MFT: mean foveal thickness, MCT: mean central thickness, MPT: mean 
peripheral thickness, MTT: mean total thickness. The outer diameter of the inner, middle and outer rings is 1, 2.22 and 3.45 millimeters 
respectively. For further definition of macular regions see Fig.1. 1Student's t-test (males vs. females)Wexler et al. BMC Ophthalmology 2010, 10:13
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differ from earlier reported data on the Stratus OCT in
whites.
Normal aging seems to affect macular cone function
[46] but not foveal cone density [47]. Most [44,45,48-54]
but not all [28,55] studies on the OCT did not report an
association between foveal thickness and age in mixed
gender group, which is in agreement with our results for
MMT. However, our data in Table 4 suggest an increase
in foveolar thickness (MMFT) with increasing age, which
also confirms Kashani et al.'s [30] observation.
How can an age-related increase in MMT be explained?
Foveolar cones rely solely on choriocapillar circulation to
satisfy their high metabolic demands, lacking retinal cap-
illaries [11]. Macular retinal [8] and foveolar choroidal
microcirculation decline with age [56], which may impair
the susceptible fovea preferentially faster [11,57]. Also
aging-related para-inflammatory responses [9] may
increase interstitial volume by impairing the blood-retina
barrier [9,58], possibly resulting in higher MMT mea-
sured by the OCT.
Bjornsson [31] reported higher prevalence of early age-
related maculopathy (EAMD) in Norwegians compared
with other ethnic populations, which might suggest the
age-related MFT increase we observed could be attrib-
uted to genetic or local environmental factors
[30,43,51,59,60]. However, this is less likely because our
MMT values were similar to those reported in other
white ethnic groups. Moreover, we found that MFT did
not increase with age in males as it did in females, sug-
gesting that hormonal factors might explain the associa-
tion between age and MMT.
Most OCT studies describe gender differences in MFT
[28,45,48,49,53,54] or in several macular areas [52,55].
Only a few studies did not find gender differences in
Table 3: Repeated measures ANOVA with three dependent regional MMT-variables (MFT, MCT and MPT).
F (df) p
Between subjects
Age1 0.28(1) 0.60
Gender1 11.2(1) 0.001
Age2 (females) 2.8(1) 0.10
Parity2 1.8(1) 0.19
Contraception3 0.58(1) 0.45
Within subjects4
Region1 153 (2) <0.0005
Region*age1 3.5 (2) 0.03
Region*gender1 4.8 (2) 0.009
Region*parity2 1.0 (2) 0.38
Region*contraception3 1.8 (2) 0.17
1First ANOVA (age and gender), 2Second ANOVA (age and parity (yes/no), females), 3Third ANOVA (age and oral contraception (yes/no), 
females). 4Multivariate repeated measures test. MMT (mean macular thickness) in three regions; MFT: mean foveal thickness (inner ring), MCT: 
mean central thickness (middle ring), MPT: mean peripheral thickness (outer ring). The outer diameter of the inner, middle and outer rings is 
1, 2.22 and 3.45 millimeters respectively. For further definition of macular regions see Fig.1
Table 4: Pearson correlation coefficients between age and mean macular thicknesses in five regions.
Both genders (n = 107) Males only (n = 45) Females only (n = 62)
F0 (MMFT) 0.20a 0.18 0.26a
Inner ring F1 (MFT) 0.08 0.03 0.28a
Middle ring (MCT) -0.08 -0.22 0.21
Outer ring (MPT) -0.07 -0.18 0.01
Total region (MTT) -0.06 -0.19 0.18
MMFT: mean minimal foveolar thickness, MFT: mean foveal thickness, MCT: mean central thickness, MPT: mean peripheral thickness, MTT: 
mean total thickness. The outer diameter of the inner, middle and outer rings is 1, 2.22 and 3.45 millimeters respectively. For further definition 
of macular regions see Fig.1. ap < 0.05Wexler et al. BMC Ophthalmology 2010, 10:13
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MMT [50,61,62]. We found gender differences in MMT
in almost all macular areas in younger but not in older
subjects, which suggest that the sexual dimorphism of the
human retina may depend on gonadal hormone levels.
Indeed, estrogen receptors seem to protect the retina
against age-inflicted injury [23,24], partly by inhibiting
lipid peroxidation [15,63,64]. Exposure to endogenous
oestrogens has been associated with lower risk for EAMD
[18,19], and exogenous estrogens seem to protect against
late age-related degeneration [14]. It may accordingly be
speculated that subclinical age-related para-inflamma-
tion may accelerate with declining estrogen levels and
possibly explain the age-related MFT increase on the
OCT in women.
P a r i t y  s e e m s  t o  l o w e r  e s t r o g e n  l ev e l s  i n  p a r o u s  p r e -
m e n o p a u s a l  c o m p a r e d  w i t h  n u l l i p a r o u s  w o m e n  [ 6 5 ] ,
partly by altering the sensitivity to sex hormones [66,67].
Reproductive history factors like long and/or irregular
menstrual cycles, early menopause, pregnancy losses and
multiparity are associated with higher risk for cardiovas-
cular disease [68]. Hence, the trend towards an associa-
tion between MMT and parity (Table 6) can possibly be
Figure 2 Mean foveal macular thickness (MFT) related to age in 
females. Linear regression is shown (Pearson correlation r = 0.28, p = 
0.03).
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Table 5: MMT (in micron(SD)) by gender, related to age (younger/older than 43) in macular regions.
Males Females p-value1
Younger group (age ≤ 43) (n = 29) (n = 27)
F0 (MMFT) 180(23) 173(19) 0.27
Inner ring F1 (MFT) 219(18) 206(15) 0.002
Middle ring MCT 281(16) 266(13) <.0005
Outer ring MPT 279(17) 272(14) 0.092
Total region MTT 274(15) 262(12) 0.003
Older group (age > 43) (n = 16) (n = 35)
F0 (MMFT) 179(18) 179(20) 0.98
Inner ring F1 (MFT) 211(15) 211(15) 0.22
Middle ring MCT 274(14) 269(12) 0.25
Outer ring MPT 272(14) 273(13) 0.84
Total region MTT 267(13) 264(12) 0.54
MMT: mean macular thickness, MMFT: mean minimal foveolar thickness, MFT: mean foveal thickness, MCT: mean central thickness, MPT: 
mean peripheral thickness, MTT: mean total thickness. The outer diameter of the inner, middle and outer rings is 1, 2.22 and 3.45 millimeters 
respectively. For further definition of macular regions see Fig.1. 1Student's t-test (males vs. females).
Figure 3 Mean foveal thickness (MFT) and mean central thickness 
(MCT) in younger (≤43 years) males and females. MFT and MCT are 
significantly thicker in males in younger subjects.
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related to a combination of hormonal and cardiovascular
risk factors.
Why did we not find any effect of contraceptives on
MMT? In the present study contraception use was
defined by as a regular oral intake for at least three
months prior to inclusion. Neither type of oral contracep-
tives nor their cumulative time of use were registered. We
did not ask about the interdependendt factors as hor-
monal replacement therapy use, menopause, number of
years from last pregnancy, lost pregnancies and multipar-
ity . I t is accordingly possible that a biologially relevant
effect of oral contraceptives on MMT could have been
demonstrated in a larger study with a suitable for this
purpose design. Anyway, it should be noted that rather
short-lasting current use of contraceptives did not seem
to affect retinal thickness.
To make participation in our study convenient, a few
younger myopic subjects kept their contact lenses on
during the OCT measurement. This could have affected
the measured MMT. Youm et al. [39] found a small
increase (1.4 μ (SD 0.5)) in measured retinal nerve fiber
layer (RNFL) (using Fast Protocol) when contacts were
removed. However, this small effect is less than 2% of the
MMT. In addition, RNFL measurements, unlike MMT
measurements, are very susceptible to low scan quality
(signal- to noise ratio and signal strength) [69,70]. Hence,
we believe that the potential effect of contact lens use
during our measurement of MMT is very small if at all
present. However, we can not exclude the possibility of a
small contact lens effect, and also this topic should be
addressed in a future study.
Conclusions
OCT measurements in healthy Norwegians did not differ
from measurements in other whites. Differences in MMT
between the genders in younger but not in older subjects
were observed. Minimal foveolar thickness in both gen-
ders and female's foveal thickness were positively associ-
ated with increasing age, while a trend towards an effect
of parity on central MMT was revealed. Age and gender
should be taken into consideration when establishing
normal ranges for MMT in younger subjects. Further
studies are needed in women to increase our understand-
ing of the possible association between MMT, parity,
aging and hormonal status.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
TBE suggested the initial concept and together with AW was responsible for
planning the study design. AW carried out the data collection including OCT
measurements. TS helped with the statistical analysis and interpretation. All
authors have participated in the writing and approval of the final manuscript.
Acknowledgements
We thank all colleagues at St. Olavs University Hospital for their effort volun-
teering for OCT measurements and disclosing relevant health related informa-
tion for the study. This study would not be possible without the administrative 
support from the head of Department of Ophthalmology, Dr Kjell-Morten 
Møen and Mrs. Guri Helene Broum Olsen. We acknowledge the contribution of 
Mrs. Ingrid Riphagen, Unit for Applied Clinical Research, Norwegian University 
of Science and Technology for managing literature references.
Table 6: MMT (SD) (in micron) related to parity among women in macular regions.
Parous women (n = 34) Nulliparous women (n = 23) p-value1
F0 (MMFT) 182(16) 170(21) 0.016
Inner ring F1 (MFT) 213(12) 205(17) 0.049
Middle ring MCT 270(12) 267(15) 0.36
Outer ring MPT 275(12) 269(14) 0.08
Total region MTT 266(11) 261(13) 0.12
MMT: mean macular thickness, MMFT: mean minimal foveolar thickness, MFT: mean foveal thickness, MCT: mean central thickness, MPT: 
mean peripheral thickness, MTT: mean total thickness. The outer diameter of the inner, middle and outer rings is 1, 2.22 and 3.45 millimeters 
respectively. For further definition of macular regions see Figure 1. 1Student's t-test (parous vs. nulliparous women).
Figure 4 Mean minimal foveolar thickness (MMFT) and mean fo-
veal thickness (MFT) in parous and nulliparous women. MMFT and 
MFT are significantly thicker in parous women.
Parity
Parous (n=34) Nulliparous (n=23)
M
i
c
r
o
n
250
225
200
175
150
65
MFT
MMFTWexler et al. BMC Ophthalmology 2010, 10:13
http://www.biomedcentral.com/1471-2415/10/13
Page 8 of 9
Author Details
1Department of Ophthalmology, St. Olavs University Hospital, Trondheim, 
Norway, 2Department of Neuroscience, Norwegian University of Science and 
Technology, Trondheim, Norway and 3Department of Neurology and Clinical 
Neurophysiology, St. Olavs University Hospital, Trondheim, Norway
References
1. van Velthoven ME, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD: 
Recent developments in optical coherence tomography for imaging 
the retina.  Prog Retin Eye Res 2007, 26(1):57-77.
2. Koozekanani D, Roberts C, Katz SE, Herderick EE: Intersession 
repeatability of macular thickness measurements with the humphrey 
2000 oct.  Invest Ophthalmol Vis Sci 2000, 41(6):1486-1491.
3. Paunescu LA, Schuman JS, Price LL, Stark PC, Beaton S, Ishikawa H, 
Wollstein G, Fujimoto JG: Reproducibility of nerve fiber thickness, 
macular thickness, and optic nerve head measurements using 
stratusoct.  Invest Ophthalmol Vis Sci 2004, 45(6):1716-1724.
4. Hsu SY, Tsai RK: Analysis of retinal nerve fiber layer and macular 
thickness measurements in healthy taiwanese individuals using 
optical coherence tomography (stratus oct).  J Glaucoma 2008, 
17(1):30-35.
5. Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A: 
Reproducibility of retinal mapping using optical coherence 
tomography.  Arch Ophthalmol 2001, 119(8):1135-1142.
6. Polito A, Del Borrello M, Isola M, Zemella N, Bandello F: Repeatability and 
reproducibility of fast macular thickness mapping with stratus optical 
coherence tomography.  Arch Ophthalmol 2005, 123(10):1330-1337.
7. Bonnel S, Mohand-Said S, Sahel JA: The aging of the retina.  Exp Gerontol 
2003, 38(8):825-831.
8. Grunwald JE, Piltz J, Patel N, Bose S, Riva CE: Effect of aging on retinal 
macular microcirculation: A blue field simulation study.  Invest 
Ophthalmol Vis Sci 1993, 34(13):3609-3613.
9. Xu HP, Chen M, Forrester JV: Para-inflammation in the aging retina.  Prog 
Retin Eye Res 2009, 28(5):348-368.
10. Kaur I, Ghanekar Y, Chakrabarti S: Understanding the genetics of age-
related macular degeneration: Some insights into the disease 
pathogenesis.  International Journal of Human Genetics 2008, 8(1-
2):161-169.
11. Penfold PL, Madigan MC, Gillies MC, Provis JM: Immunological and 
aetiological aspects of macular degeneration.  Prog Retin Eye Res 2001, 
20(3):385-414.
12. Ting AYC, Lee TKM, MacDonald IM: Genetics of age-related macular 
degeneration.  Curr Opin Ophthalmol 2009, 20(5):369-376.
13. Deschenes MC, Descovich D, Moreau M, Granger L, Kuchel GA, Mikkola TS, 
Fick GH, Chemtob S, Vaucher E, Lesk MR: Postmenopausal hormone 
therapy increases retinal blood flow and protects the retinal nerve 
fiber layer.  Invest Ophthalmol Vis Sci 2010, 51(5):2587-600.
14. Velez DR, Gallins P, Polk M, Ayala-Haedo J, Schwartz SG, Kovach JL, 
Spencer KM, Wang G, Agarwal A, Postel E, et al.: Inverse association of 
female hormone replacement therapy and oral contraceptive use with 
age-related macular degeneration and interactions with arms2 
polymorphisms.  Invest Ophthalmol Vis Sci 2010, 51(4):1873-1879.
15. Dincer Y, Ozen E, Kadioglu P, Hatemi H, Akcay T: Effect of sex hormones 
on lipid peroxidation in women with polycystic ovary syndrome, 
healthy women, and men.  Endocr Res 2001, 27(3):309-316.
16. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, 
Willett WC: A prospective study of cigarette smoking and risk of 
colorectal adenoma and colorectal cancer in u.S. Men.  J Natl Cancer Inst 
1994, 86(3):183-191.
17. Gupta PD, Johar K, Nagpal K, Vasavada AR: Sex hormone receptors in the 
human eye.  Surv Ophthalmol 2005, 50(3):274-284.
18. Smith W, Mitchell P, Wang JJ: Gender, oestrogen, hormone replacement 
and age-related macular degeneration. Results from the blue 
mountains eye study.  Aust N Z J Ophthalmol 1997, 25:S13-S15.
19. Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE: 
Menopausal and reproductive factors and risk of age-related macular 
degeneration.  Arch Ophthalmol 2008, 126(4):519-524.
20. Evans JR, Schwartz SD, McHugh JDA, Thamby-Rajah Y, Hodgson SA, 
Wormald RPL, Gregor ZJ: Systemic risk factors for idiopathic macular 
holes: A case-control study.  Eye 1998, 12:256-259.
21. Eisner A, Toomey MD: The color appearance of stimuli detected via 
short-wavelength-sensitive cones: Comparisons with visual adaptation 
and visual field data for peri- or post-menopausal women under 70 
years of age.  Vision Res 2008, 48(26):2663-2672.
22. Jagle H, Heine J, Kurtenbach A: L:M-cone ratio estimates of the outer 
and inner retina and its impact on sex differences in erg amplitudes.  
Doc Ophthalmol 2006, 113(2):105-113.
23. Elliot S, Catanuto P, Fernandez P, Espinosa-Heidmann D, Karl M, Korach K, 
Cousins SW: Subtype specific estrogen receptor action protects against 
changes in mmp-2 activation in mouse retinal pigmented epithelial 
cells.  Exp Eye Res 2008, 86(4):653-660.
24. Elliot SJ, Catanuto P, Espinosa-Heidmann DG, Fernandez P, Hernandez E, 
Saloupis P, Korach K, Karl M, Cousins SW: Estrogen receptor beta protects 
against in vivo injury in rpe cells.  Exp Eye Res 2010, 90(1):10-16.
25. Klein R, Klein BEK, Knudtson MD, Wong TY, Cotch MF, Liu K, Burke G, Saad 
MF, Jacobs DR: Prevalence of age-related macular degeneration in 4 
racial/ethnic groups in the multi-ethnic study of atherosclerosis.  
Ophthalmology 2006, 113(3):373-380.
26. Loh FH, Khin LW, Saw SM, Lee JJM, Gu K: The age of menopause and the 
menopause transition in a multiracial population. A nation-wide 
singapore study.  Maturitas 2005, 52(3-4):169-180.
27. Asefzadeh B, Cavallerano AA, Fisch BM: Racial differences in macular 
thickness in healthy eyes.  Optom Vis Sci 2007, 84(10):941-945.
28. Guedes V, Schuman JS, Hertzmark E, Wollstein G, Correnti A, Mancini R, 
Lederer D, Voskanian S, Velazquez L, Pakter HM, et al.: Optical coherence 
tomography measurement of macular and nerve fiber layer thickness 
in normal and glaucomatous human eyes.  Ophthalmology 2003, 
110(1):177-189.
29. Huynh SC, Wang XY, Rochtchina E, Mitchell P: Distribution of macular 
thickness by optical coherence tomography: Findings from a 
population-based study of 6-year-old children.  Invest Ophthalmol Vis Sci 
2006, 47(6):2351-2357.
30. Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV, Eliott DE, Haller 
JA, Nguyen QD: Retinal thickness analysis by race, gender, and age 
using stratus oct.  Am J Ophthalmol 2010, 149(3):496-502.
31. Bjornsson OM, Syrdalen P, Bird AC, Peto T, Kinge B: The prevalence of 
age-related maculopathy (arm) in an urban norwegian population: 
The oslo macular study.  Acta Ophthalmol Scand 2006, 84(5):636-641.
32. Dratva J, Real FG, Schindler C, Ackermann-Liebrich U, Gerbase MW, 
Probst-Hensch NM, Svanes C, Omenaas ER, Neukirch F, Wjst M, et al.: Is 
age at menopause increasing across europe? Results on age at 
menopause and determinants from two population-based studies.  
Menopause-J N Am Menopause Soc 2009, 16(2):385-394.
33. Jacobsen BK, Heuch I, Kvale G: Age at natural menopause and all-cause 
mortality: A 37-year follow-up of 19,731 norwegian women.  Am J 
Epidemiol 2003, 157(10):923-929.
34. Jacobsen BK, Heuch I, Kvale G: Age at natural menopause and stroke 
mortality - cohort study with 3561 stroke deaths during 37-year follow-
up.  Stroke 2004, 35(7):1548-1551.
35. Mikkelsen TF, Graff-Iversen S, Sundby J, Bjertness E: Early menopause, 
association with tobacco smoking, coffee consumption and other 
lifestyle factors: A cross-sectional study.  BMC Public Health 2007, 7:149.
36. Sehi M, Guaqueta DC, Feuer WJ, Greenfield DS: A comparison of 
structural measurements using 2 stratus optical coherence 
tomography instruments.  J Glaucoma 2007, 16(3):287-292.
37. Wang XY, Huynh SC, Burlutsky G, Ip J, Stapleton F, Mitchell P: 
Reproducibility of and effect of magnification on optical coherence 
tomography measurements in children.  Am J Ophthalmol 2007, 
143(3):484-488.
38. Smith M, Frost A, Graham CM, Shaw S: Effect of pupillary dilatation on 
glaucoma assessments using optical coherence tomography.  Br J 
Ophthalmol 2007, 91(12):1686-1690.
39. Youm DJ, Kim JM, Park KH, Choi CY: The effect of soft contact lenses 
during the measurement of retinal nerve fiber layer thickness using 
optical coherence tomography.  Curr Eye Res 2009, 34(1):78-83.
40. Barkana Y, Burgansky-Eliash Z, Gerber Y, Melamed S, Neudorfer M, Avni I, 
Bartov E, Morad Y: Inter-device variability of the stratus optical 
coherence tomography.  Am J Ophthalmol 2009, 147(2):260-266.
Received: 16 December 2009 Accepted: 13 May 2010 
Published: 13 May 2010
This article is available from: http://www.biomedcentral.com/1471-2415/10/13 © 2010 Wexler et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Ophthalmology 2010, 10:13Wexler et al. BMC Ophthalmology 2010, 10:13
http://www.biomedcentral.com/1471-2415/10/13
Page 9 of 9
41. Muscat S, Parks S, Kemp E, Keating D: Repeatability and reproducibility 
of macular thickness measurements with the humphrey oct system.  
Invest Ophthalmol Vis Sci 2002, 43(2):490-495.
42. Lima-Gomez V, Ojeda-Cruz P: Concordance of two retinal mapping 
techniques to detect diabetic macular edema.  Cir Cir 2009, 77(2):83-87.
43. Liew SHM, Gilbert CE, Spector TD, Mellerio J, Van Kuijk FJ, Beatty S, Fitzke F, 
Marshall J, Hammond CJ: Central retinal thickness is positively 
correlated with macular pigment optical density.  Exp Eye Res 2006, 
82(5):915-920.
44. Chamberlain MD, Guymer RH, Dirani M, Hopper JL, Baird PN: Heritability 
of macular thickness determined by optical coherence tomography.  
Invest Ophthalmol Vis Sci 2006, 47(1):336-340.
45. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS: Normal macular 
thickness measurements in healthy eyes using stratus optical 
coherence tomography.  Arch Ophthalmol 2006, 124(2):193-198.
46. Falsini B, Ziccardi L, Stifano G, Iarossi G, Merendino E, Minnella AM, Fadda 
A, Balestrazzi E: Temporal response properties of the macular cone 
system: Effect of normal aging and age-related maculopathy.  Invest 
Ophthalmol Vis Sci 2007, 48(10):4811-4817.
47. Curcio CA, Millican CL, Allen KA, Kalina RE: Aging of the human 
photoreceptor mosaic - evidence for selective vulnerability of rods in 
central retina.  Invest Ophthalmol Vis Sci 1993, 34(12):3278-3296.
48. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, 
Swanson EA, Fujimoto JG: Topography of diabetic macular edema with 
optical coherence tomography.  Ophthalmology 1998, 105(2):360-370.
49. Lam DSC, Leung KS, Mohamed S, Chan WM, Palanivelu MS, Cheung CYL, 
Li EYM, Lai RYK, Leung CKS: Regional variations in the relationship 
between macular thickness measurements and myopia.  Invest 
Ophthalmol Vis Sci 2007, 48(1):376-382.
50. Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccheri B, Fiore T, Maestranzi 
G: Macular thickness measured by optical coherence tomography (oct) 
in diabetic patients.  Eur J Ophthalmol 2002, 12(6):482-487.
51. Liew SHM, Gilbert CE, Spector TD, Marshall J, Hammond CJ: The role of 
heredity in determining central retinal thickness.  Br J Ophthalmol 2007, 
91(9):1143-1147.
52. Wakitani Y, Sasoh M, Sugimoto M, Ito Y, Ido M, Uji Y: Macular thickness 
measurements in healthy subjects with different axial lengths using 
optical coherence tomography.  Retina 2003, 23(2):177-182.
53. Wong ACM, Chan CWN, Hui SP: Relationship of gender, body mass 
index, and axial length with central retinal thickness using optical 
coherence tomography.  Eye 2005, 19(3):292-297.
54. Kelty PJ, Payne JF, Trivedi RH, Kelty J, Bowie EM, Burger BM: Macular 
thickness assessment in healthy eyes based on ethnicity using stratus 
oct optical coherence tomography.  Invest Ophthalmol Vis Sci 2008, 
49(6):2668-2672.
55. Huang JJ, Liu X, Wu ZQ, Xiao H, Dustin L, Sadda S: Macular thickness 
measurements in normal eyes with time-domain and fourier-domain 
optical coherence tomography.  Retina 2009, 29(7):980-987.
56. Grunwald JE, Hariprasad SM, DuPont J: Effect of aging on foveolar 
choroidal circulation.  Arch Ophthalmol 1998, 116(2):150-154.
57. Provis JM: Development of the primate retinal vasculature.  Prog Retin 
Eye Res 2001, 20(6):799-821.
58. Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, Van 
Nieuwenhuyzen P, Hu P: Inflammation and breakdown of the blood-
retinal barrier during "physiological aging" in the rat retina: A model 
for cns aging.  Microcirculation 2007, 14(1):63-76.
59. Hogg RE, Dimitrov PN, Dirani M, Varsamidis M, Chamberlain MD, Baird PN, 
Guymer RH, Vingrys AJ: Gene-environment interactions and aging 
visual function a classical twin study.  Ophthalmology 2009, 
116(2):263-269.
60. Wolf-Schnurrbusch UEK, Roosli N, Weyermann E, Heldner MR, Hohne K, 
Wolf S: Ethnic differences in macular pigment density and distribution.  
Invest Ophthalmol Vis Sci 2007, 48(8):3783-3787.
61. El-Ashry M, Hegde V, James P, Pagliarini S: Analysis of macular thickness 
in british population using optical coherence tomography (oct). An 
emphasis on interocular symmetry.  Curr Eye Res 2008, 33(8):693-699.
62. Grover S, Murthy RK, Brar VS, Chalam KV: Normative data for macular 
thickness by high-definition spectral-domain optical coherence 
tomography (spectralis).  Am J Ophthalmol 2009, 148(2):266-271.
63. Wachnik A, Biro G, Biro L, Korom M, Gergely A, Antal M: Effect of sex-
hormones on copper, zinc, iron nutritional-status and hepatic lipid-
peroxidation in rats.  Nahr-Food 1993, 37(1):28-34.
64. Yagi K, Komura S: Inhibitory effect of female hormones on lipid-
peroxidation.  Biochem Int 1986, 13(6):1051-1055.
65. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE: Estrogen 
and sex hormone-binding globulin levels in nulliparous and parous 
women.  J Natl Cancer Inst 1985, 74(4):741-745.
66. Byrnes EM, Babb JA, Bridges RS: Differential expression of oestrogen 
receptor alpha following reproductive experience in young and 
middle-aged female rats.  J Neuroendocrinol 2009, 21(6):550-557.
67. Bridges RS, Byrnes EM: Reproductive experience reduces circulating 
17beta-estradiol and prolactin levels during proestrus and alters 
estrogen sensitivity in female rats.  Endocrinology 2006, 
147(5):2575-2582.
68. de Kleijn MJ, Schouw YT van der, Graaf Y van der: Reproductive history 
and cardiovascular disease risk in postmenopausal women: A review of 
the literature.  Maturitas 1999, 33(1):7-36.
69. Stein DM, Wollstein G, Ishikawa H, Hertzmark E, Noecker RJ, Schuman JS: 
Effect of corneal drying on optical coherence tomography.  
Ophthalmology 2006, 113(6):985-991.
70. Wu ZQ, Huang JJ, Dustin L, Sadda SR: Signal strength is an important 
determinant of accuracy of nerve fiber layer thickness measurement 
by optical coherence tomography.  J Glaucoma 2009, 18(3):213-216.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2415/10/13/prepub
doi: 10.1186/1471-2415-10-13
Cite this article as: Wexler et al., Macular thickness measurements in healthy 
Norwegian volunteers: an optical coherence tomography study BMC Oph-
thalmology 2010, 10:13